{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:58:43Z","timestamp":1762459123758},"reference-count":22,"publisher":"Elsevier BV","issue":"1-2","content-domain":{"domain":["jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jns.2013.09.031","type":"journal-article","created":{"date-parts":[[2013,9,29]],"date-time":"2013-09-29T04:19:10Z","timestamp":1380428350000},"page":"197-200","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Presence of paraneoplastic antibodies in non-carcinomatous patients with neurological involvements of unknown cause"],"prefix":"10.1016","volume":"335","author":[{"given":"Masaru","family":"Yanagihashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyokazu","family":"Kawabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2013.09.031_bb0005","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/brain\/88.3.529","article-title":"Immunofluorescent detection of antibodies against neurons in sensory carcinomatous neuropathy","volume":"88","author":"Wilkinson","year":"1965","journal-title":"Brain"},{"key":"10.1016\/j.jns.2013.09.031_bb0010","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1084\/jem.141.6.1365","article-title":"Experimental autoimmune myasthenia: a model of myasthenia gravis in rats and guinea pigs","volume":"141","author":"Lennon","year":"1975","journal-title":"J Exp Med"},{"key":"10.1016\/j.jns.2013.09.031_bb0015","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMra023009","article-title":"Paraneoplastic syndromes involving the nervous system","volume":"349","author":"Darnell","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jns.2013.09.031_bb0020","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00401-011-0876-1","article-title":"Paraneoplastic encephalomyelopathies: pathology and mechanisms","volume":"122","author":"McKeon","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jns.2013.09.031_bb0025","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1212\/WNL.50.6.1806","article-title":"Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes","volume":"50","author":"Vernino","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2013.09.031_bb0030","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.10518","article-title":"Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments","volume":"53","author":"Pittock","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2013.09.031_bb0035","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.20269","article-title":"Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome","volume":"56","author":"Pittock","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2013.09.031_bb0040","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2013.09.031_bb0045","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/jnnp.2007.125930","article-title":"Neuropathy in lymphoma: a relationship between the pattern of neuropathy, type of lymphoma and prognosis?","volume":"79","author":"Viala","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2013.09.031_bb0050","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/jnnp.54.9.764","article-title":"Neurological paraneoplastic syndromes in patients with small cell lung cancer: a prospective survey of 150 patients","volume":"54","author":"Elrington","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2013.09.031_bb0055","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","article-title":"Paraneoplastic syndromes of the CNS","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"issue":"pt 3","key":"10.1016\/j.jns.2013.09.031_bb0060","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awh077","article-title":"Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis","volume":"127","author":"Vincent","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.jns.2013.09.031_bb0065","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1212\/01.WNL.0000122648.19196.02","article-title":"Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody","volume":"62","author":"Thieben","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2013.09.031_bb0070","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1212\/01.wnl.0000312275.04260.a0","article-title":"Clinical spectrum of voltage-gated potassium channel autoimmunity","volume":"70","author":"Tan","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2013.09.031_bb0075","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jns.2013.09.031_bb0080","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1212\/WNL.46.5.1391","article-title":"Calcium channel blockers and transmitter release at the normal human neuromuscular junction","volume":"46","author":"Protti","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2013.09.031_bb0085","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/jnnp.58.1.85","article-title":"An improved diagnostic assay for Lambert\u2013Eaton myasthenic syndrome","volume":"58","author":"Motomura","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2013.09.031_bb0090","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s004150050303","article-title":"Specificity of \u03c9-conotoxin MVIIC binding and blocking calcium channel antibodies in Lambert\u2013Eaton myasthenic syndrome","volume":"246","author":"Nakao","year":"1999","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2013.09.031_bb0095","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/brain\/111.3.577","article-title":"The Lambert\u2013Eaton myasthenic syndrome: a review of 50 cases","volume":"111","author":"O'Neill","year":"1988","journal-title":"Brain"},{"key":"10.1016\/j.jns.2013.09.031_bb0100","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1212\/01.WNL.0000037485.56217.5F","article-title":"Seronegative Lambert\u2013Eaton myasthenic syndrome: study of 110 Japanese patients","volume":"59","author":"Nakano","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2013.09.031_bb0105","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/01.nrl.0000259483.70041.55","article-title":"Autoimmune encephalopathies","volume":"13","author":"Vernino","year":"2007","journal-title":"Neurologist"},{"key":"10.1016\/j.jns.2013.09.031_bb0110","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0896-6273(90)90077-S","article-title":"Ligand-gated ion channels in the brain: the amino acid receptor superfamily","volume":"5","author":"Betz","year":"1990","journal-title":"Neuron"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X13029407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X13029407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T16:48:36Z","timestamp":1564159716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X13029407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":22,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0022510X13029407"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2013.09.031","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Presence of paraneoplastic antibodies in non-carcinomatous patients with neurological involvements of unknown cause","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2013.09.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}